CTMX vs VRTX: Which Stock is Better?
Side-by-side comparison of CytomX Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026
CTMX
CytomX Therapeutics Inc
—
VRTX
Vertex Pharmaceuticals Inc
$480.50
Key Metrics Comparison
| Metric | CTMX | VRTX | Winner |
|---|---|---|---|
| Market Cap | $653.11M | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CTMX
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or VRTX a better investment?
Comparing CTMX and VRTX: CytomX Therapeutics Inc has a market cap of $653.11M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and VRTX?
CTMX (CytomX Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CTMX or VRTX?
Both CTMX and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CTMX or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CTMX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $653.11M for CTMX.
Should I buy CTMX or VRTX in 2026?
Both CTMX and VRTX have investment merit. CTMX trades at $N/A while VRTX trades at $480.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and VRTX stock?
Key differences: Market Cap ($653.11M vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CTMX or VRTX in 2026?
The choice between CTMX and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CTMX and VRTX?
CTMX (CytomX Therapeutics Inc) has a market cap of $653.11M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.